PT - JOURNAL ARTICLE AU - Kazmers, Nikolas H. AU - Meeks, Huong D. AU - Novak, Kendra A. AU - Yu, Zhe AU - Fulde, Gail L. AU - Thomas, Joy L. AU - Barker, Tyler AU - Jurynec, Michael J. TI - Familial clustering of erosive hand osteoarthritis in a large statewide cohort AID - 10.1101/2020.04.04.20053264 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.04.20053264 4099 - http://medrxiv.org/content/early/2020/04/16/2020.04.04.20053264.short 4100 - http://medrxiv.org/content/early/2020/04/16/2020.04.04.20053264.full AB - Objectives Erosive hand osteoarthritis (EOA) is a severe and rapidly progressing form of osteoarthritis. Its etiology remains largely unknown, which has hindered development of successful treatments. Our primary goal was to test the hypothesis that EOA would demonstrate familial clustering in a large statewide population linked to genealogical records, which would suggest a genetic contribution to the pathogenesis of this condition. Our secondary purpose was to determine the association of potential risk factors with EOA.Methods Patients diagnosed with EOA were identified by searching medical records from a comprehensive statewide database, the Utah Population Database (UPDB). Affected individuals were then mapped to pedigrees to identify high-risk families with excess clustering of EOA as defined by a Familial Standardized Incidence Ratio (FSIR) of ≥ 2.0. The magnitude of familial risk of EOA in related individuals was calculated using Cox regression models. Association of potential EOA risk factors was analyzed using conditional logistic regression and logistic regression models.Results We identified 703 affected individuals linked to 240 unrelated high-risk pedigrees with excess clustering of EOA (FSIR ≥ 2.0). The relative risk of developing EOA was significantly elevated in first-degree relatives. There was a significant association with the diagnosis of EOA and age, sex, diabetes, and obesity.Conclusions Familial clustering of EOA observed in a statewide database indicates a potential genetic contribution to the etiology of the disease. Identification of causal gene variants in these high-risk families may provide insight into the genes and pathways that contribute to EOA onset and progression.Competing Interest StatementThe authors have declared no competing interest.Funding Statement: This study was funded by the Skaggs Foundation for Research and the Utah Genome Project (M.J.J. and N.H.K.). We thank Dr. Rena D’Souza for critical feedback. We acknowledge the Pedigree and Population Resource of the Huntsman Cancer Institute for its support of the UPDB. We also acknowledge partial support for the UPDB through grant P30 CA2014 from the NCI and from the University of Utah’s Program in Personalized Health and Center for Clinical and Translational Science.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon reasonable request.